<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03729713</url>
  </required_header>
  <id_info>
    <org_study_id>2018001642</org_study_id>
    <nct_id>NCT03729713</nct_id>
  </id_info>
  <brief_title>Computerized Cognitive Rehabilitation in MS Patients</brief_title>
  <official_title>Computerized Cognitive Rehabilitation in MS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Horizon Blue Cross Blue Shield of New Jersey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines a home-based computerized cognitive rehabilitation intervention in adults&#xD;
      with multiple sclerosis compared to placebo (videogame). Patients are assessed through&#xD;
      pre-and post neuropsychological testing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized to enter a 6 week course of computer based cognitive&#xD;
      rehabilitation focused on improving attention, learning, and memory. Control patients will&#xD;
      receive an alternative home-based computer program not designed for cognitive remediation but&#xD;
      of the same duration.&#xD;
&#xD;
      The primary outcome will be performance on neuropsychological testing in the intervention&#xD;
      sample compared to controls. Secondary outcomes will be the measures of self-efficacy, work&#xD;
      productivity, quality of life, fatigue, depression, anxiety, and healthcare utilization.&#xD;
      Healthcare utilization variables include annual total cost (current year and prior), number&#xD;
      and cost of ER/hospital/outpatient visits, number of hospital visits, hospital length of&#xD;
      stay, number preventive visits, total number claims, and number of new medications initiated.&#xD;
      In addition, acute changes in neuropsychological testing induced by a bout of physical&#xD;
      activity (i.e. self-paced walking during the Six-Minute Walk Test) will be examined, and that&#xD;
      pattern of change will be compared between intervention and control groups at each data&#xD;
      collection point.&#xD;
&#xD;
      Each subject will participate for a total of 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 21, 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Placebo controlled</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive Functioning</measure>
    <time_frame>6 Months</time_frame>
    <description>Compare between groups differences in attention (auditory and visual working memory), processing speed (automatic and controlled speed), executive functioning (verbal fluency and mental flexibility), and memory (immediate and delayed verbal and visual modalities) at completion of intervention, 3 months and 6 months using standardized scores.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Multiple Sclerosis Self-Efficacy Scale</measure>
    <time_frame>6 Months</time_frame>
    <description>Measures the person's perspective on maintenance and control over their multiple sclerosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work Productivity and Activity Impairment Instrument</measure>
    <time_frame>6 months</time_frame>
    <description>Measures a person's impairments in their ability to work and participate in chosen activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiple Sclerosis Quality of Life Inventory</measure>
    <time_frame>6 months</time_frame>
    <description>A battery of quality of life scales designed for use by people with MS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>6 months</time_frame>
    <description>Measures depression and anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare Utilization</measure>
    <time_frame>12 Months</time_frame>
    <description>Compare between group differences in annual cost of care, ER visits, hospital visits, hospital length of stay, number of preventive visits, total number of claims, and neurology office visits</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Six-minute Walk Test</measure>
    <time_frame>6 months</time_frame>
    <description>A measure of walking endurance - measures how far a person can walk in six minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Timed Up &amp; Go Test</measure>
    <time_frame>6 months</time_frame>
    <description>A timed test of functional mobility that tests a persons ability to stand, walk a short distance and return to sitting.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Multiple Sclerosis</condition>
  <condition>Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Computerized Cognitive Rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Video game</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Computerized cognitive rehabilitation</intervention_name>
    <description>6 week course of cognitive rehabilitation focused on attention, learning, and memory</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham placebo</intervention_name>
    <description>an alternative home-based computer program not designed for cognitive remediation but of the same duration</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1. Diagnosis of multiple sclerosis with cognitive complaint&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients unwilling to participate&#xD;
&#xD;
          2. Patients who cannot attend NPT sessions&#xD;
&#xD;
          3. Patients with severe cognitive impairment&#xD;
&#xD;
          4. Non-English speaking patients (testing materials are in English)&#xD;
&#xD;
          5. Patients with intact neuropsychological functioning at baseline on testing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08091</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 1, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2018</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Vikram Bhise, MD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

